Inmune Bio Files 8-K Report

Ticker: INMB · Form: 8-K · Filed: Apr 14, 2025 · CIK: 1711754

Inmune Bio, Inc. 8-K Filing Summary
FieldDetail
CompanyInmune Bio, Inc. (INMB)
Form Type8-K
Filed DateApr 14, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 8-k, filing, financials

TL;DR

Inmune Bio filed an 8-K. Check for updates on financials/events.

AI Summary

On April 14, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This filing signals that Inmune Bio, Inc. is providing updates to the SEC, which could contain important information for investors regarding the company's financial health or significant operational developments.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report without specific negative or positive disclosures in the provided text, suggesting a low immediate risk.

Key Players & Entities

  • Inmune Bio, Inc. (company) — Registrant
  • April 14, 2025 (date) — Date of earliest event reported
  • Nevada (jurisdiction) — State of incorporation
  • 001-38793 (identifier) — Commission File Number
  • 47-5205835 (identifier) — IRS Employer Identification No.
  • 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432 (address) — Address of Principal Executive Offices
  • 858-964-3720 (phone_number) — Registrant's Telephone Number

FAQ

What specific "Other Events" are being reported by Inmune Bio, Inc. on April 14, 2025?

The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included.

Are there any new financial statements or exhibits being filed with this 8-K?

Yes, the filing indicates "Financial Statements and Exhibits" as an item information category, suggesting that such documents are part of this report.

What is Inmune Bio, Inc.'s state of incorporation and IRS Employer Identification Number?

Inmune Bio, Inc. is incorporated in Nevada and has an IRS Employer Identification Number of 47-5205835.

Where are Inmune Bio, Inc.'s principal executive offices located?

The principal executive offices of Inmune Bio, Inc. are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.

What is the Commission File Number for Inmune Bio, Inc.?

The Commission File Number for Inmune Bio, Inc. is 001-38793.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding Inmune Bio, Inc. (INMB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.